Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
1.
Arch Pediatr ; 23(9): 944-50, 2016 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-27476994

RESUMO

Progress made in the field of perinatology over the past four decades has led to unprecedented low mortality rates for extremely low birth weight infants. However, because rates of important short-term complications and neurodevelopmental impairment among survivors have remained high, the best approach to borderline viable infants continues to be debated. Not surprisingly, guidelines from various national medical societies for the care of infants born at the limit of viability vary considerably. In 2002, the first Swiss recommendations for the care of borderline viable infants were published. They had been developed by a multidisciplinary team of experts from the fields of obstetrics, pediatrics, and neonatology. Despite the availability of national guidelines, center-to-center outcome variability has since persisted, suggesting that care for the most immature infants is not only evidence-based and guideline-driven but also strongly influenced by local neonatal intensive care unit (NICU) culture. In 2011, revised national recommendations for perinatal care at the limit of viability between 22 and 26 completed weeks of gestation were published. It remains to be seen whether this has led to more uniform outcomes across the Swiss centers in the years that followed.


Assuntos
Recém-Nascido de Peso Extremamente Baixo ao Nascer , Lactente Extremamente Prematuro , Assistência Perinatal/normas , Guias de Prática Clínica como Assunto , Cuidados Críticos , Idade Gestacional , Humanos , Recém-Nascido , Cuidados Paliativos , Assistência Perinatal/ética , Suíça
2.
New Microbes New Infect ; 3: 41-5, 2015 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-25755892

RESUMO

Waddlia chondrophila and Chlamydia trachomatis are intracellular bacteria associated with human miscarriage. We investigated their role in human preterm birth. Whereas presence of Chlamydia trachomatis DNA in genital tract was associated with human preterm birth, Waddlia was not, despite being present in women's genital tracts.

3.
Clin Microbiol Infect ; 20(10): 1074-9, 2014 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-24849820

RESUMO

Mycoplasma hominis and Ureaplasma spp. may colonize the human genital tract and have been associated with adverse pregnancy outcomes such as preterm labour and preterm premature rupture of membranes. However, as these bacteria can reside in the normal vaginal flora, there are controversies regarding their true role during pregnancy and so the need to treat these organisms. We therefore conducted a retrospective analysis to evaluate the treatment of genital mycoplasma in 5377 pregnant patients showing symptoms of potential obstetric complications at 25-37 weeks of gestation. Women presenting with symptoms were routinely screened by culture for the presence of these bacteria and treated with clindamycin when positive. Compared with uninfected untreated patients, women treated for genital mycoplasma demonstrated lower rates of premature labour. Indeed preterm birth rates were, respectively, 40.9% and 37.7% in women colonized with Ureaplasma spp. and M. hominis, compared with 44.1% in uncolonized women (Ureaplasma spp., p 0.024; M. hominis, p 0.001). Moreover, a reduction of neonatal complications rates was observed, with 10.9% of newborns developing respiratory diseases in case of Ureaplasma spp. colonization and 5.9% in the presence of M. hominis, compared with 12.8% in the absence of those bacteria (Ureaplasma spp., p 0.050; M. hominis, p <0.001). Microbiological screening of Ureaplasma spp. and/or M. hominis and pre-emptive antibiotic therapy of symptomatic pregnant women in late pregnancy might represent a beneficial strategy to reduce premature labour and neonatal complications.


Assuntos
Antibacterianos/uso terapêutico , Clindamicina/uso terapêutico , Infecções por Mycoplasmatales/tratamento farmacológico , Complicações Infecciosas na Gravidez/tratamento farmacológico , Nascimento Prematuro/prevenção & controle , Infecções do Sistema Genital/tratamento farmacológico , Síndrome do Desconforto Respiratório do Recém-Nascido/prevenção & controle , Adulto , Feminino , Humanos , Recém-Nascido , Pessoa de Meia-Idade , Mycoplasma/crescimento & desenvolvimento , Infecções por Mycoplasmatales/microbiologia , Gravidez , Complicações Infecciosas na Gravidez/microbiologia , Resultado da Gravidez , Nascimento Prematuro/epidemiologia , Nascimento Prematuro/etiologia , Infecções do Sistema Genital/microbiologia , Síndrome do Desconforto Respiratório do Recém-Nascido/complicações , Síndrome do Desconforto Respiratório do Recém-Nascido/epidemiologia , Síndrome do Desconforto Respiratório do Recém-Nascido/etiologia , Estudos Retrospectivos , Ureaplasma/crescimento & desenvolvimento , Adulto Jovem
4.
Rev Med Suisse ; 10(418): 430-4, 2014 Feb 19.
Artigo em Francês | MEDLINE | ID: mdl-24640278

RESUMO

Major improvements in perinatal care have led to increased survival after premature birth and have allowed the survival of very young and immature newborns. Bronchopulmonary dysplasia is a serious complication of prematurity and has become a developmental lung disorder, hardly preventable due to its multiple causes. The treatment serves to maintain a normal growth, reduce the respiratory workload, and prevent further complications, by trying not to interfer with postnatal lung development. Bronchopulmonary dysplasia may be associated with bronchial hyperreactivity and an obstructive bronchial pattern that may lead to frequent hospital admissions for reactive airway disease in the small child, and contribute to the persistence of chronic lung disease mainly as a new chronic obstructive pulmonary disease phenotype in adulthood.


Assuntos
Hiper-Reatividade Brônquica/terapia , Displasia Broncopulmonar/terapia , Pneumopatias/etiologia , Adulto , Hiper-Reatividade Brônquica/etiologia , Hiper-Reatividade Brônquica/fisiopatologia , Displasia Broncopulmonar/etiologia , Displasia Broncopulmonar/fisiopatologia , Criança , Doença Crônica , Hospitalização/estatística & dados numéricos , Humanos , Lactente , Recém-Nascido , Recém-Nascido Prematuro , Pneumopatias/epidemiologia , Pneumopatias/fisiopatologia , Doença Pulmonar Obstrutiva Crônica/epidemiologia , Doença Pulmonar Obstrutiva Crônica/etiologia , Doença Pulmonar Obstrutiva Crônica/fisiopatologia
5.
Placenta ; 35(1): 44-9, 2014 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-24280234

RESUMO

INTRODUCTION: Intrauterine Growth Restriction (IUGR) is a multifactorial disease defined by an inability of the fetus to reach its growth potential. IUGR not only increases the risk of neonatal mortality/morbidity, but also the risk of metabolic syndrome during adulthood. Certain placental proteins have been shown to be implicated in IUGR development, such as proteins from the GH/IGF axis and angiogenesis/apoptosis processes. METHODS: Twelve patients with term IUGR pregnancy (birth weight < 10th percentile) and 12 CTRLs were included. mRNA was extracted from the fetal part of the placenta and submitted to a subtraction method (Clontech PCR-Select cDNA Subtraction). RESULTS: One candidate gene identified was the long non-coding RNA NEAT1 (nuclear paraspeckle assembly transcript 1). NEAT1 is the core component of a subnuclear structure called paraspeckle. This structure is responsible for the retention of hyperedited mRNAs in the nucleus. Overall, NEAT1 mRNA expression was 4.14 (±1.16)-fold increased in IUGR vs. CTRL placentas (P = 0.009). NEAT1 was exclusively localized in the nuclei of the villous trophoblasts and was expressed in more nuclei and with greater intensity in IUGR placentas than in CTRLs. PSPC1, one of the three main proteins of the paraspeckle, co-localized with NEAT1 in the villous trophoblasts. The expression of NEAT1_2 mRNA, the long isoform of NEAT1, was only modestly increased in IUGR vs. CTRL placentas. DISCUSSION/CONCLUSION: The increase in NEAT1 and its co-localization with PSPC1 suggests an increase in paraspeckles in IUGR villous trophoblasts. This could lead to an increased retention of important mRNAs in villous trophoblasts nuclei. Given that the villous trophoblasts are crucial for the barrier function of the placenta, this could in part explain placental dysfunction in idiopathic IUGR fetuses.


Assuntos
Retardo do Crescimento Fetal/fisiopatologia , Placenta/fisiopatologia , RNA Longo não Codificante/metabolismo , Trofoblastos/metabolismo , Adulto , Núcleo Celular/metabolismo , Feminino , Humanos , Gravidez
6.
J Reprod Immunol ; 94(2): 175-82, 2012 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-22436290

RESUMO

Successful implantation is still the limiting step in IVF. We hypothesized that maternal plasma concentrations of certain cytokines at the time of embryo transfer could predict the likelihood of successful implantation and pregnancy. sIL-2R, IL-6, LIF, and MMP2 concentrations were measured in plasma from 160 IVF patients (natural and stimulated IVF cycles) on the morning of the embryo transfer (ET0) and 14 days later (ET+14). Patients were ultimately subdivided into four groups depending on the IVF treatment outcome (pregnancy failure, biochemical pregnancy, first-trimester miscarriage and normal term delivery). In natural and stimulated IVF cycles at ET0, sIL-2R concentrations were threefold higher in biochemical pregnancies than in pregnancy failures (P=0.020), and in natural cycles only, 2.5-fold higher in normal term deliveries than in pregnancy failures (P=0.023). Conversely, in natural and stimulated IVF cycles at ET0, LIF concentrations were one third lower in biochemical pregnancies/first-trimester miscarriages compared with pregnancy failures (P=0.042). We suggest that high sIL-2R and low LIF concentrations in maternal plasma on the morning of the embryo transfer might be associated with increased risks of early pregnancy loss, while a basal level of sIL-2R is necessary for normal term delivery outcome. Both cytokine measurements might therefore be useful in the management of IVF patients, and modulation of their concentrations could be investigated as a therapeutic alternative for women with abnormal concentrations at the time of embryo transfer.


Assuntos
Fertilização in vitro , Infertilidade/diagnóstico , Infertilidade/terapia , Fator Inibidor de Leucemia/sangue , Receptores de Interleucina-2/sangue , Adulto , Biomarcadores/sangue , Transferência Embrionária , Feminino , Seguimentos , Humanos , Infertilidade/imunologia , Metaloproteinase 2 da Matriz/sangue , Valor Preditivo dos Testes , Prognóstico , Estudos Prospectivos , Resultado do Tratamento
8.
Neonatology ; 97(4): 339-45, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19940517

RESUMO

Few cases of severe postnatally acquired cytomegalovirus (CMV) infection are reported in premature infants. We report on an extremely low birthweight (ELBW) preterm infant who presented with a sepsis-like syndrome and multiple organ involvement, notably pneumonitis and colitis. The course of infection was assessed by repeated analysis of urine, tracheal aspirates and blood. The patient was given intravenous ganciclovir. The clinical course was rapidly favorable. Development of neutropenia led to the discontinuation of the antiviral treatment after 28 days. Follow-up showed moderate white matter anomalies on cerebral MRI, a transient hypoacusis and a mild developmental delay at 18 months of corrected age. To the best of our knowledge, this is the first description of a severe combination of pneumonitis and colitis in postnatal CMV infection. Many issues remain controversial and are discussed. We propose that antiviral treatment should be considered in severe postnatal CMV infection in ELBW patients.


Assuntos
Colite/complicações , Infecções por Citomegalovirus/complicações , Recém-Nascido de Peso Extremamente Baixo ao Nascer , Pneumonia/complicações , Síndrome de Resposta Inflamatória Sistêmica/complicações , Adulto , Colite/congênito , Infecções por Citomegalovirus/congênito , Feminino , Humanos , Lactente , Recém-Nascido , Pneumonia/congênito , Gravidez , Índice de Gravidade de Doença , Síndrome de Resposta Inflamatória Sistêmica/congênito
9.
Rev Med Suisse ; 5(185): 53-8, 2009 Jan 07.
Artigo em Francês | MEDLINE | ID: mdl-19216326

RESUMO

This year we present three papers on recent advances in paediatrics from the fields of neonatology, adolescent medicine and Duchenne muscular dystrophy. 1. Recent studies question the application of pure oxygen for neonatal reanimation and suggest that lower concentrations or even air may be more adequate for the reanimation of most newborns. 2. Bullying is an aggressive, repetitive and intentionally blessing behaviour. It is observed mainly at school and the victims are usually children with a weak personality or children suffering from chronic diseases. The doctor's role is to detect this behaviour and to help protect the victims. 3. The respiratory surveillance of patients with Duchenne muscular dystrophy is the corner-stone of their management. An algorithm allows to time correctly the initiation of non-invasive ventilation and to insure as long as possible a good life quality.


Assuntos
Pediatria/tendências , Comportamento Agonístico , Algoritmos , Criança , Salas de Parto , Humanos , Recém-Nascido , Distrofia Muscular de Duchenne/fisiopatologia , Ressuscitação
10.
Rev Med Suisse ; 4(146): 504-6, 508, 2008 Feb 27.
Artigo em Francês | MEDLINE | ID: mdl-18402401

RESUMO

In Switzerland, the rate of respiratory distress in neonates needing hospitalization has doubled over the last thirty years, concerning in particular babies weighing more than 2500 g. In the same time, the rate of Caesarean section (CS) has also multiplied. We suppose that a link between the two evolutions might be the increase of elective CS. They tend to be planned early at term to avoid the onset of spontaneous labour As a consequence, the foetus is deprived of different mechanisms helping pulmonary transition around birth. The potential benefits of CS regarding morbidity of foetus and mother should not overshadow that CS is a significant risk factor for respiratory problems of the neonate. This risk could be dramatically decreased by planning elective CS only after completed 39 weeks of gestation.


Assuntos
Cesárea/estatística & dados numéricos , Síndrome do Desconforto Respiratório do Recém-Nascido/epidemiologia , Peso ao Nascer/fisiologia , Feminino , Maturidade dos Órgãos Fetais/fisiologia , Idade Gestacional , Humanos , Recém-Nascido , Pulmão/embriologia , Gravidez , Medição de Risco , Fatores de Risco , Suíça/epidemiologia
11.
Neonatology ; 92(1): 14-8, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17596732

RESUMO

We report 2 cases of non-immune hydrops fetalis (NIHF) in which autopsy findings revealed an association with right-sided congenital diaphragmatic eventration (CDE). Both patients born at 30 weeks of gestation presented with severe generalized skin oedema, pleural effusions and ascites. They both died shortly after birth of cardiorespiratory insufficiency due to lung hypoplasia and low output heart failure. The right thoracic cavity was filled with the membranous but intact right diaphragm covering the herniated visceral organs including parts of the liver, small bowel and colon surrounded by voluminous ascites. In similar fashion to the situation seen in congenital diaphragmatic hernia (CDH), the displaced visceral organs led to impaired lung growth resulting in important lung hypoplasia and obstructed venous return. Extravascular liquid accumulation was probably further aggravated by hypoproteinaemia secondary to liver dysfunction resulting from the venous congestion and cardiac failure. In summary, CDE is a rare condition resulting from impaired ingrowth of muscle fibres into the diaphragm during the first trimester. Prenatal differentiation of CDE from CDH is a real challenge. The association of CDE and NIHF has not been previously described.


Assuntos
Eventração Diafragmática/complicações , Hidropisia Fetal/etiologia , Autopsia , Baixo Débito Cardíaco/complicações , Diafragma/anormalidades , Eventração Diafragmática/diagnóstico , Feminino , Hérnia Diafragmática/complicações , Hérnias Diafragmáticas Congênitas , Humanos , Hidropisia Fetal/diagnóstico , Recém-Nascido
12.
Rev Med Suisse ; 2(83): 2356-7, 2359-64, 2006 Oct 18.
Artigo em Francês | MEDLINE | ID: mdl-17112087

RESUMO

From the standpoint of the pediatrician, the new knowledges in perinatology allowed progresses in certain fields (identification of high risk pregnancies, decrease in perinatal mortality, decrease of major handicaps in high risk newborns). However, the new knowledge's did not improve the rate of preterm deliveries. Some aspects of antenatal and intrapartum fetal assessment as well as the postnatal evaluation of the newborn will be discussed. The figures and tables summarize data directly linked to the practitioner's every day's concerns.


Assuntos
Doenças Fetais , Doenças do Recém-Nascido/diagnóstico , Desenvolvimento Fetal , Doenças Fetais/diagnóstico , Doenças Fetais/terapia , Humanos , Recém-Nascido , Doenças do Recém-Nascido/terapia , Pediatria , Perinatologia , Diagnóstico Pré-Natal , Fatores de Risco
13.
Pediatrics ; 107(6): 1264-71, 2001 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-11389241

RESUMO

OBJECTIVES: The early discharge of neonates from hospitals makes transcutaneous measurement of total bilirubin concentration a useful tool to monitor neonatal jaundice. The objectives of this study were to determine whether 1) transcutaneous bilirubin (TcB) measurement, as performed using BiliCheck (BC), correlates with total serum bilirubin (TSB) levels, measured with standard laboratory methods and with high-pressure liquid chromatography (HPLC-B); 2) infant race, gestational age, postnatal age, or body weight interferes with the measurement of TcB levels in newborn infants; 3) the variability of the TcB measurement is comparable to the variability of TSB measurements; and 4) TcB measurements obtained from the forehead (BCF) and sternum (BCS) generate comparable results. STUDY DESIGN: Newborn infants who were <28 days and >30 weeks' gestational age and who underwent tests for TSB as part of their normal care in 6 different European hospitals were studied. A total of 210 infants were enrolled in the study, 35 at each site. Near simultaneous (within +/- 30 minutes) blood collection for TSB and BCF and BCS measurements were performed. TSB levels were determined by the serum bilirubin method in use at each site, and all HPLC-B determinations were made at the same, independent laboratory. RESULTS: The study group consisted of 140 white, 31 Asian, 14 Hispanic, 9 African, and another 16 newborns of different races. The correlation coefficient (r) between BCF and HPLC-B was 0.890 (95% confidence interval = 0.858-0.915). BCF and BCS generated similar results (r value = 0.890 for BCF and 0.881 for BCS), even if BCS slightly overestimated (mean error = -0.04 mg/dL) and BCF slightly underestimated (mean error = 0.96 mg/dL) in comparison with HPLC-B. Analysis of covariance demonstrated that BC accuracy was independent of race, birth weight, gestational age, and postnatal age of the newborn. Receiver operating characteristic curves were evaluated for BCF and TSB, each compared with HPLC-B. With the use of a cutoff point for HPLC-B of 13 mg/dL (222 micromol/L) and a cutoff of 11 mg/dL on the BCF and TSB, similar sensitivity/specificity (93%/73% for BCF, 95%/76% for TSB) were observed. The use of a cutoff point for HPLC-B of 17 mg/dL (290 micromol/L) and 14 mg/dL (240 micromol/L) for BCF and TSB also produced similar sensitivity/specificity (90%/87% for the BC and 87%/83% for TSB). CONCLUSIONS: Because the correlation coefficient for HPLC-B and BCF is very similar to that found for HPLC-B and laboratory TSB, BC could be used not only as a screening device but also as a reliable substitute of TSB determination. At higher levels of TSB, in which phototherapy and/or exchange transfusion might be considered, BC performed slightly better than the laboratory. The accuracy and precision of the TcB measurement in this study was observed to be comparable to the standard of care laboratory test.


Assuntos
Bilirrubina/sangue , Recém-Nascido/sangue , Peso ao Nascer , Cromatografia Líquida de Alta Pressão/métodos , Cromatografia Líquida de Alta Pressão/normas , Desenho de Equipamento , Estudos de Avaliação como Assunto , Idade Gestacional , Humanos , Icterícia Neonatal/sangue , Icterícia Neonatal/diagnóstico , Luz , Triagem Neonatal/instrumentação , Triagem Neonatal/métodos , Valor Preditivo dos Testes , Curva ROC , Padrões de Referência , Sensibilidade e Especificidade , Análise Espectral/instrumentação , Análise Espectral/métodos
14.
Praxis (Bern 1994) ; 86(49): 1934-7, 1997 Dec 03.
Artigo em Alemão | MEDLINE | ID: mdl-9480514

RESUMO

In order to update our information concerning immunization coverage in Switzerland we analysed data from the public school immunization program of the canton of Aargau between 1988-90. We compared these results with those of two districts from the school year 1993-94. 97% of all the matriculating or graduating school children could be reached. As expected, the immunization rates of 98% for poliomyelitis and 96% for diphtheria/tetanus were high. Following initiation of the nationwide MMR (Measles/Mumps/Rubella) Immunization Program in 1987, coverage of preschool children with the MMR-vaccination could be improved from 44% in the late 1980's to 70-80% in the early 1990's. As a result of offering the vaccine free of charge to all matriculating and graduating children, the MMR-immunization rate could be increased to 90-94%, and the measles immunization rate even further to 97% indicating the importance of the school immunization program. This high level of acceptance in Aargau shows that an increase in the immunization rate even in infant and preschool children can be realised, if the pediatricians and the general practitioners improve their efforts. In regions with similar epidemiological conditions MMR-reimmunization in school children is to be recommended.


Assuntos
Programas de Imunização , Esquemas de Imunização , Serviços de Saúde para Estudantes , Criança , Pré-Escolar , Toxoide Diftérico/administração & dosagem , Feminino , Humanos , Lactente , Masculino , Vacina contra Sarampo/administração & dosagem , Vacina contra Caxumba/administração & dosagem , Vacina Antipólio de Vírus Inativado/administração & dosagem , Vacina contra Rubéola/administração & dosagem , Suíça
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA